About Event
Europe’s Premier Platform Uniting Microbiome R&D & Microbial Therapeutics Leaders
The 9th Microbiome Movement Summit Europe is the industry’s definitive event, uniting a driven community at the cutting edge of microbiome research to showcase data unequivocally proving the therapeutic potential of microbial modalities.
As the crucial yearly touchpoint for fresh and familiar faces to collaborate and network, C-Level executives, R&D leaders, commercial experts and investors will converge to bridge the translational gap, unlock mechanisms of action and shape agile pipeline strategies that fast-track promising programmes to patients.
Key Features for 2025:
Discover Clinical Trial Design Optimisations
Analyse effective clinical trial designs for LBPs and Whole-Ecosystem products, focussing on patient selection, recruitment, control measures and combination strategies with Biomica, MRM Health, Maat pharma, and Seres Therapeutics
Learn About Emerging Therapeutic Targets in GI & Beyond
Discover cutting-edge evidence linking microbiota composition and activity to new therapeutic avenues, across the gut-brain axis, women’s health, respiratory, and cardiometabolic disease and more, though a dedicated focus day
Navigate the Current Regulatory & Commercial Environment
Review Microbiotica’s regulatory path to Phase I and explore BioGaia Pharma and Luca Bio’s business models to expedite therapeutic development through probiotic pathways. Insights from Seventure, SOSV, EIT Health, M Ventures, CSB, and Innovate UK Business Connect spotlight strategies for driving engagement with investor stakeholders
Uncover Analytical Approaches to Delve into Mechanisms of Action
Explore how spatial biology, AI platforms and multi-omic dataset integration is accelerating target discovery, strain selection and translation to the clinic, as Kanvas Biosciences, PharmaBiome, and Exceliom Biosciences share methodologies to overcome data integrity challenges
New Presenters Joining Us in 2025:
Who Will You Meet?
